OraQuick HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick HIV ...

Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...

There was a major victory in the battle against HIV/AIDS recently when the Food and Drug Administration approved the first easy-to-use “rapid” test for HIV, called OraQuick. This test provides results ...

A Lehigh Valley company that helped transform HIV testing is continuing its mission to improve public health through innovation and accessibility.

BETHLEHEM, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its ...

WASHINGTON - People will soon be able to learn before leaving the doctor's office if they're infected with the AIDS virus. The government on Thursday approved a 20-minute HIV test that AIDS experts ...

BETHLEHEM, Pa., Dec. 13, 2010 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its ...

BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...

With in-person health services limited due to the ongoing COVID-19 pandemic, Greater Than AIDS, a public information initiative of KFF, and Walgreens are partnering together. Together, the companies ...

Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...

BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV ...